Study of HD Mesh Ablation System for Treatment of Paroxysmal Atrial Fibrillation

PHASE3TerminatedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Paroxysmal Atrial Fibrillation
Interventions
DEVICE

HD Mesh Ablation System

Ablation using the HD Mesh Ablation System

DRUG

Anti-arrhythmic drugs

5 anti-arrhythmic drugs administered at the labeled dosage for atrial fibrillation

Trial Locations (13)

18103

Lehigh Valley Heart Specialists, Allentown

30309

Piedmont Hospital Research Institute, Atlanta

32224

Mayo Clinic, Jacksonville

32610

University of Florida, Gainesville

32803

Florida Heart Group, Orlando

33607

Bay Heart Group, Tampa

65807

St. John's Medical Research Institute, Springfield

80012

Aurora Denver Cardiology Associates, Aurora

92103

University of California, San Diego Medical Center, San Diego

04401

Northeast Cardiology Associates, Bangor

02114

Massachusetts General Hospital, Boston

02135

Caritas St. Elizabeth's Medical Center, Boston

02903

Rhode Island Hospital, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
lead

C. R. Bard

INDUSTRY

NCT00741611 - Study of HD Mesh Ablation System for Treatment of Paroxysmal Atrial Fibrillation | Biotech Hunter | Biotech Hunter